Saturday, July 4, 2020
Home 2020 May

Monthly Archives: May 2020

Checkpoint Theraputics
Interview

11:00 AM Webinar Today, Checkpoint Therapeutics (CKPT) CEO James Olivero.

Editor / Curator -
Immunomedics, Biotech Stock Review
Biotech News

Immunomedics (IMMU) $33 | Raising Price Potential to $60. American BriVision...

Editor / Curator -
Organicell
Superbug News

Corona Craziness Continues. Organicell (BPSR) Gains 10-fold or 1000%, in Six...

Editor / Curator -
Superbug News

MRSA: Can Kill Within 24 Hours. Here Are Some Basics.

Editor / Curator -
All News

MRSA: Methicillin (antibiotic) Resistant Staphylococcus Aureus.

Editor / Curator -
Organicell
Infections

Organicell (BPSR) a Triple Since Easter.

Editor / Curator -
video
Stand Down

Stand Down X: Peter Shiff, “We Have Run Out of Road,...

Editor / Curator -
Telehealth

How CoronaVirus Accelerated the Rise of Telemedicine (CNBC).

Editor / Curator -
All News

After FDA authorizes at-home saliva test for Covid-19, startups begin selling...

Editor / Curator -
Biotech Stock Review
All News

Biotech Stock Review Adds One Medical (ONEM) $28.50 to Watchlist.

Editor / Curator -
12Page 1 of 2

Latest article

Citius (CTXR) CEO Myron Holubiak Live on TV, 1:20 Today, June 30th.

2020 Watch List Editor / Curator -
VIDEO: Citius CEO Myron Holubiak to Appear on TD Ameritrade Network's The Watch List with Nicole Petallides
Citius Pharma

Citius Pharma (CTXR) On The Move.

2020 Watch List Editor / Curator -
One Of Our Top 5 Biotech Picks For 2020 Up 23% Yesterday, Indicating Up Another 24% This Morning. Inquiring Minds Want...
Biotech Stock Review

Meet The Billion-Dollar Family Company That Makes Purell (Forbes).

Superbug News Editor / Curator -
Jerry and Goldie Lippman cofounded Gojo in Akron, Ohio, in 1946. Forbes 3/20/2020 Panic buying is...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.